Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

RMD open

Showing results (911-920 of 1,920) with videos related to

Pageof 192
Sort By:
RMD Open|September 6, 2023
Rituximab for the treatment of acute exacerbation of interstitial lung disease associated with connective tissue diseaseFrancisco León Román, Beatriz Pintado-Cort, Diana García-Casado, et al.
RMD Open|September 6, 2023
Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohortsHelga Westerlind, Bente Glintborg, Hilde Berner Hammer, et al.
RMD Open|August 31, 2023
Developing a framework for the implementation of recommendations for lifestyle factors for people with RMDs across Europe: assessment of current materials and implementation needsJavier Rodríguez-Carrio, Giulio Cavalli, James Gwinnutt, et al.
RMD Open|August 31, 2023
Developing evidence-based patient-focused learning materials to support health behaviour change for people living with psoriatic arthritisLouise Hailey, Laura Howells, Christine Bundy, et al.
RMD Open|August 31, 2023
Phase 3, multicentre, randomised, double-blind, placebo-controlled, parallel-group study of ustekinumab in Japanese patients with active polymyositis and dermatomyositis who have not adequately responded to one or more standard-of-care treatmentsKimito Kawahata, Tomonori Ishii, Takahisa Gono, et al.
RMD Open|September 15, 2023
Incidence of infections in patients with psoriatic arthritis and axial spondyloarthritis treated with biological or targeted disease-modifying agents: a systematic review and meta-analysis of randomised controlled trials, open-label studies and observational studiesMelanie Aureal, Milene Seauve, Soline Laplane, et al.
RMD Open|April 9, 2026
Birth length and perinatal exposures and rheumatoid arthritis risk in the E3N cohortPerrine Dusser, Yann Nguyen, Claire Perrin, et al.
RMD Open|April 9, 2026
Persistent arthritis develops in joints previously affected by palindromic flares: a longitudinal study investigating the transition from palindromic rheumatism to rheumatoid arthritisDidem Sahin, Rahaymin Chowdhury, Andrea Di Matteo, et al.
RMD Open|April 9, 2026
Emotional well-being at diagnosis may indicate future mental health risk in patients with juvenile idiopathic arthritis: data from the German inception cohort ICONPrasad T Oommen, Jens Klotsche, Rainer Berendes, et al.
RMD Open|April 10, 2026
Immunoprecipitation-mass spectrometry reveals known and novel (NatC, <i>BCS1L</i>) antinuclear antibodies in rheumatoid arthritisJonas De Leeuw, Birthe Michiels, Rita Derua, et al.
Pageof 192

Showing results (911-920 of 1,920) with videos related to

Sort By:
Pageof 192
RMD Open|September 6, 2023
Rituximab for the treatment of acute exacerbation of interstitial lung disease associated with connective tissue diseaseFrancisco León Román, Beatriz Pintado-Cort, Diana García-Casado, et al.
RMD Open|September 6, 2023
Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohortsHelga Westerlind, Bente Glintborg, Hilde Berner Hammer, et al.
RMD Open|August 31, 2023
Developing a framework for the implementation of recommendations for lifestyle factors for people with RMDs across Europe: assessment of current materials and implementation needsJavier Rodríguez-Carrio, Giulio Cavalli, James Gwinnutt, et al.
RMD Open|August 31, 2023
Developing evidence-based patient-focused learning materials to support health behaviour change for people living with psoriatic arthritisLouise Hailey, Laura Howells, Christine Bundy, et al.
RMD Open|August 31, 2023
Phase 3, multicentre, randomised, double-blind, placebo-controlled, parallel-group study of ustekinumab in Japanese patients with active polymyositis and dermatomyositis who have not adequately responded to one or more standard-of-care treatmentsKimito Kawahata, Tomonori Ishii, Takahisa Gono, et al.
RMD Open|September 15, 2023
Incidence of infections in patients with psoriatic arthritis and axial spondyloarthritis treated with biological or targeted disease-modifying agents: a systematic review and meta-analysis of randomised controlled trials, open-label studies and observational studiesMelanie Aureal, Milene Seauve, Soline Laplane, et al.
RMD Open|April 9, 2026
Birth length and perinatal exposures and rheumatoid arthritis risk in the E3N cohortPerrine Dusser, Yann Nguyen, Claire Perrin, et al.
RMD Open|April 9, 2026
Persistent arthritis develops in joints previously affected by palindromic flares: a longitudinal study investigating the transition from palindromic rheumatism to rheumatoid arthritisDidem Sahin, Rahaymin Chowdhury, Andrea Di Matteo, et al.
RMD Open|April 9, 2026
Emotional well-being at diagnosis may indicate future mental health risk in patients with juvenile idiopathic arthritis: data from the German inception cohort ICONPrasad T Oommen, Jens Klotsche, Rainer Berendes, et al.
RMD Open|April 10, 2026
Immunoprecipitation-mass spectrometry reveals known and novel (NatC, <i>BCS1L</i>) antinuclear antibodies in rheumatoid arthritisJonas De Leeuw, Birthe Michiels, Rita Derua, et al.
Pageof 192